Curcumin modulation of atherosclerosis and hepatosteatosis in LDLr-/- mice

被引：0
|
作者：
Hasan, Syeda Tahira [1 ]
Zingg, Jean-Marc [1 ]
Noble, Timothy [1 ]
Kwan, Paul [3 ]
Smith, Donald [2 ]
Meydani, Mohsen [1 ]
机构：
[1] Tufts Univ, HNRCA, Vasc Biol Lab, Boston, MA 02111 USA
[2] Tufts Univ, HNRCA, Comparat Biol Unit, Boston, MA 02111 USA
[3] Tufts Univ, Sch Med, Boston, MA 02111 USA
来源：
FASEB JOURNAL | 2013年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
359.1
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Therapeutic silencing of FSP27 reduces the progression of atherosclerosis in Ldlr-/- mice
    Rajamoorthi, Ananthi
    Lee, Richard G.
    Baldan, Angel
    ATHEROSCLEROSIS, 2018, 275 : 43 - 49
  • [42] Prevention of atherosclerosis by the mTOR inhibitor everolimus in LDLR-/- mice despite severe hypercholesterolemia
    Mueller, Marc A.
    Beutner, Frank
    Teupser, Daniel
    Ceglarek, Uta
    Thiery, Joachim
    ATHEROSCLEROSIS, 2008, 198 (01) : 39 - 48
  • [43] The Citrus Flavonoid Nobiletin Prevents Dyslipidemia, Hepatic Steatosis, and Atherosclerosis in Ldlr-/- Mice
    Mulvihill, Erin E.
    Koppes, Julie B.
    Assini, Julia M.
    Sutherland, Brian G.
    Edwards, Jane Y.
    Sawyez, Cythia G.
    Huff, Murray W.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (11) : E248 - E248
  • [44] ATORVASTATIN ATTENUATES ATHEROSCLEROSIS IN THE VALVES AND FEMURS FROM HYPERCHOLESTEROLEMIC LDLR-/-MICE AS=OP
    Rajamannan, N. M.
    CARDIOLOGY, 2014, 128 : 247 - 247
  • [45] IL-21R BLOCKADE REDUCES ATHEROSCLEROSIS DEVELOPMENT IN LDLR-/- MICE
    Postel, R. J.
    Smit, V.
    De Mol, J.
    Kleijn, M. N. A. Bernabe
    De Jong, M. J. M.
    Delfos, L.
    Hemme, E.
    Depuydt, M. A. C.
    Bot, I.
    Kuiper, J.
    Foks, A. C.
    ATHEROSCLEROSIS, 2022, 355 : E105 - E106
  • [46] Interleukin-12 deficiency decreases atherosclerosis in LDLR-/-, Rag-/- mice
    Nakajima, C
    Nakajima, Y
    Counselman, J
    Bradshaw, G
    Boisvert, WA
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (05) : A79 - A79
  • [47] Liraglutide Reduces Both Atherosclerosis and Kidney Inflammation in Moderately Uremic LDLr-/- Mice
    Bisgaard, Line S.
    Bosteen, Markus H.
    Fink, Lisbeth N.
    Sorensen, Charlotte M.
    Rosendahl, Alexander
    Mogensen, Christina K.
    Rasmussen, Salka E.
    Rolin, Bidda
    Nielsen, Lars B.
    Pedersen, Tanja X.
    PLOS ONE, 2016, 11 (12):
  • [48] The Genetic Interval Sle1 is Sufficient to Accelerate Atherosclerosis in LDLr-/- Mice
    Wilhelm, Ashley J.
    Rhoads, Jillian P.
    Major, Amy S.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2014, 34
  • [49] The immunosuppressant everolimus significantly prevents atherosclerosis in LDLR-/- mice despite severe hypercholesterolemia
    Mueller, M. A.
    Beutner, F.
    Teupser, D.
    Ceglarek, U.
    Jeromin, F.
    Wilfert, W.
    Thiery, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (02): : S251 - S251
  • [50] Danhong Injection Inhibits the Development of Atherosclerosis in Both Apoe-/- and Ldlr-/- Mice
    Chen, Yuanli
    Liu, Mengyang
    Zhao, Tao
    Zhao, Buchang
    Jia, Lifu
    Zhu, Yan
    Zhang, Boli
    Gao, Xiumei
    Li, Guangliang
    Li, Xiaoju
    Xiang, Rong
    Han, Jihong
    Duan, Yajun
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2014, 63 (05) : 441 - 452
12345